Form 4: McKesson EVP and Chief Legal Officer Reports Routine Stock Transactions Following RSU Vesting
Insider Transaction Report
Michele Lau, EVP and Chief Legal Officer of McKesson Corp., reported the vesting of Restricted Stock Units and subsequent stock transactions, including tax-related share disposals, on May 21, 2025.
Summary
- Michele Lau, Executive Vice President and Chief Legal Officer of McKesson Corp. (MCK), reported stock transactions on May 21, 2025, as detailed in a Form 4 filing.
- The transactions included the acquisition of 724 shares of common stock resulting from the vesting of Restricted Stock Units (RSUs), with a transaction price of $0.
- Concurrently, 285 shares of common stock were disposed of at a price of $718.73 per share to cover tax withholding obligations related to the RSU vesting.
- Following these reported transactions, Michele Lau directly holds 3,247 shares of McKesson common stock.
- Additionally, 138.4685 shares are indirectly beneficially owned through the McKesson Corporation 401(k) Retirement Savings Plan.
- A total of 1,449 Restricted Stock Units remain outstanding, with future vesting scheduled for one-third on May 21, 2026, and the final one-third on May 21, 2027.
Sentiment
Score: 6
Explanation: The document reports routine executive compensation events (RSU vesting and tax-related share disposal), which are generally neutral but reflect ongoing executive alignment with company performance. No significant positive or negative operational news is conveyed.
Positives
- The vesting of Restricted Stock Units (RSUs) for the EVP and Chief Legal Officer signifies the realization of a component of executive compensation, which is typically tied to long-term performance and aligns management's interests with shareholder value.
Negatives
- The disposal of 285 shares to cover tax obligations, while a standard practice for RSU vesting, results in a reduction of the executive's direct common stock holdings.
Future Outlook
The remaining Restricted Stock Units (RSUs) held by Michele Lau are scheduled to vest in two equal tranches: one-third on May 21, 2026, and the final one-third on May 21, 2027, indicating future compensation realization.
Industry Context
This Form 4 filing reflects routine executive compensation practices within the healthcare distribution and technology industry, where Restricted Stock Units (RSUs) are a common component of long-term incentive plans designed to align executive interests with shareholder performance.
Stakeholder Impact
- Shareholders: The vesting of RSUs and subsequent tax-related share sales by an executive are routine and reflect the operation of executive compensation plans, which aim to align management incentives with shareholder interests.
- Employees: No direct impact mentioned beyond the executive's compensation.
Next Steps
- Future vesting of remaining Restricted Stock Units (RSUs) on May 21, 2026, and May 21, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of earliest transaction, including RSU vesting and stock acquisition/disposal. |
| 05/23/2025 | Date the Form 4 was signed by the attorney-in-fact. |
| 05/21/2026 | Future vesting date for 1/3 of remaining Restricted Stock Units. |
| 05/21/2027 | Future vesting date for 1/3 of remaining Restricted Stock Units. |
Keywords
McKesson, MCK, Form 4, SEC filing, insider trading, stock transactions, Restricted Stock Units, RSU vesting, executive compensation, Michele Lau
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.